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A B S T R A C T   
The intestinal epithelium is a monolayer of polarized columnar cells that act as a border between the host and its 
environment and are the first line of defence against the luminal microbes. In addition to providing a physical 
barrier, the epithelium possesses a multitude of active mechanisms to fight invading pathogens and regulate the 
composition and spatial distribution of commensals. The different epithelial cell types have unique functions in 
this context, and crosstalk with the immune system further modulates their intricate antimicrobial responses. 
The epithelium is organized into clonal crypt units with a high cellular turnover that is driven by stem cells 
located at the base. There is increasing evidence that this anatomical organization, the stem cell turnover, and 
the lineage determination processes are essential for barrier maintenance. These processes can be modulated by 
microbes directly or by the immune responses to enteric pathogens, resulting in a rapid and efficient adaptation 
of the epithelium to environmental perturbations, injuries, and infections. Here we discuss the complex host- 
microbial interactions that shape the mucosa and how the epithelium maintains and re-establishes homeosta-
sis after infection.   
1. Introduction 
The gastrointestinal epithelium is a vital interface between the host 
and the environment. Its main function is to absorb nutrients, which 
requires close contact with the luminal content of the gut. On the other 
hand, the epithelium acts as a barrier between the environment and the 
organism and is equipped to protect the host from invading pathogens 
and their virulence factors. We discuss here how the epithelium main-
tains this semi-permeable border, focusing on its anatomical structure 
and the various cell types that constitute the mucosa. Each cell type is 
equipped with unique defence mechanisms, which together maintain an 
efficient antimicrobial barrier. We describe here the diverse properties 
of different epithelial cell types that regulate commensals and defend 
against pathogens, highlighting new insights on the critical role of 
gastrointestinal stem cells. Stem cells are responsible for the rapid 
turnover of the epithelium, and also act as sensors and effectors during 
infection and injury. These cells have an exceptional ability to respond 
to a variety of environmental and internal niche signals. They modulate 
the epithelial barrier function by facilitating remarkably specific 
epithelial responses to environmental perturbations, thereby playing a 
key role in re-establishing and maintaining homeostasis. Commensal 
and pathogenic microbes have been shown to affect stem cell behaviour, 
which has an impact on the regenerative capacity of the epithelium, as 
well as the ability of the host to fight infectious agents. 
2. Anatomical structure and turnover of the epithelium 
The entire gastrointestinal epithelium is organized as invaginations 
called crypts, with protrusions called villi present only in the small in-
testine. This architecture serves to increase the surface area, allowing for 
maximum nutritional absorption by enterocytes located at the surface, 
while minimizing the exposure of the crypt base to the luminal content. 
The gastrointestinal epithelium is characterized by extremely high cell 
turnover, which is driven by long-lived stem cells located at the base of 
the crypts. They are marked by leucine-rich repeat-containing G-protein 
coupled receptor 5 (LGR5) - the receptor for the Wnt-agonist R-spondin 
(Barker et al., 2007). Stem cells give rise to rapidly proliferating 
transit-amplifying (TA) cells in the lower part of the crypts, which 
subsequently differentiate into absorptive or secretory cell lineages. 
Except for the Paneth cells of the small intestine, which remain in the 
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crypts, the other cell types differentiate into a mature phenotype as they 
migrate up from the crypts to replace extruded cells. The epithelium has 
a rapid turnover period of 3–5 days for the small intestine and 5–7 days 
for the large intestine (Barker, 2014), which helps expel any damaged or 
mutated cells (Fig. 1). The mucosa of the stomach is also organized as 
crypts, which due to their mainly secretory function are called glands, 
with stem cells located at both the base and the isthmus of the glands. 
Several key regulatory signals, such as the Wnt, epidermal growth factor 
(EGF) and Notch pathways, are active at the crypt base and are essential 
for the maintenance of the stem cell niche. In contrast, members of the 
transforming growth factor-beta (TGF-β) superfamily of ligands, such as 
bone morphogenetic proteins (BMPs), negatively regulate stemness and 
are active towards the upper part of the crypt (Gehart and Clevers, 
2019). In healthy epithelium, a precise balance is maintained between 
cellular proliferation and cell death. As differentiated cells only have a 
lifespan of a few days, it is damage to the long-lived stem and progenitor 
cells at the crypt base that can critically impair epithelial integrity. 
3. Stem cells 
Stem cells are crucial for the epithelial turnover in the healthy state 
and for the regenerative response after epithelial injury. Recent insights 
suggest that they are not only master regulators of regeneration and 
maintenance, but also act as sensors and effectors during microbial in-
fections, mediating epithelial defence and modulating immune 
responses. 
Epithelial stem cells were originally considered sterile due to their 
location all the way at the base of the crypts and their proximity to 
secretory antimicrobial Paneth cells in the small intestine. It has now 
become clear that this notion does not hold true for the entire gastro-
intestinal tract. In the murine cecum and colon, a “crypt-specific core 
microbiota” has been demonstrated and regulation of stem cell activity 
by such bacteria has been suggested (Naito et al., 2017; Pedron et al., 
2012). Using a murine model of infection with the gastric pathogen 
Helicobacter pylori, we were able to demonstrate that the bacteria are 
able to colonize deep inside the glands of the stomach and directly 
attach to stem cells (Sigal et al., 2015). This leads to a sequence of 
events, resulting in expansion of stem cells and increased proliferative 
activity. This is partially mediated by upregulation of the stem cell niche 
factor R-spondin 3, which is secreted by myofibroblasts directly below 
the gland base, and which controls the number of stem cells and their 
activity (Sigal et al., 2017). Strikingly, R-spondin driven responses to 
infection also result in differentiation of a subset of Lgr5+ cells in the 
gland base into secretory, antimicrobial cells which secrete a multitude 
of antimicrobial proteins to fight infection. We found that expression of 
some of these proteins, such as intelectin-1, is dependent on R-spondin 3 
and depletion of R-spondin 3 or Lgr5+ stem cells leads to increased 
colonialization of gastric glands with H. pylori. We also observed that 
intelectin-1 binds to H. pylori in a calcium-dependent manner, impairing 
its motility (Sigal et al., 2019). These results demonstrate the remark-
able ability of gastric stem cells and their immediate microenvironment 
to respond to an infection and to mediate an epithelial response to 
defend against the bacterial invasion and simultaneously enhance 
regeneration. Similar to the stomach, the role of R-spondin has also been 
demonstrated in intestinal infections. Citrobacter rodentium infection 
results in increased stromal expression of R-spondin 2, which causes a 
Wnt-mediated proliferative response of colonic crypt cells (Papapietro 
et al., 2013). This study showed that R-spondin can be harmful, leading 
to an overwhelming proliferative response that results in diarrhoea and 
increased mortality. Proliferation of stem cells has even been observed 
as a response to epithelial injury in the villus caused by rotavirus 
infection and it has been demonstrated that Wnt ligands secreted by the 
epithelium are essential for this regenerative process (Zou et al., 2018). 
Accelerated intestinal epithelial cell turnover has likewise been sug-
gested as a mechanism for expulsion of the mucin-degrading bacteria 
Akkermansia muciniphila in the small intestine (Kim et al., 2020) and the 
parasite Trichuris trichuria in the large intestine (Cliffe et al., 2005). The 
number and proliferative activity of stem cells have also been shown to 
be altered by infection with a parasitic helminth, in this case leading to a 
loss of Lgr5+ stem cells, while simultaneously re-activating fetal-like 
stem cells that support the repair of injured tissue (Nusse et al., 2018). A 
similar process has also been demonstrated in the context of experi-
mental colitis (Yui et al., 2018). In contrast, certain 
lactic-acid-producing bacteria have been shown to expand intestinal 
stem cells, Paneth cells, and goblet cells in response to injury (Lee et al., 
2018). In addition to bacteria, their metabolites can also have an impact 
on stem cell proliferation. During homeostasis, bacterial fermentation of 
fibre-derived sugars produces short-chain fatty acids (SCFAs), such as 
butyrate, which reduces stemness and inhibits the expansion of the stem 
cell compartment (Kaiko et al., 2016). Overall, these data suggest that 
various microbes and their by-products can modulate the functions of 
stem cells, leading to expansion, loss, or reprogramming of these cells, 
which in turn has an impact on the composition and integrity of the 
epithelium. 
Recent reports also suggest that stem cell responses to environmental 
alterations are regulated by the immune system. In the small intestine, T 
helper cells or their cytokines have been shown to interact with stem 
cells upon bacterial or helminth infection, suppressing stem cell renewal 
and promoting differentiation toward Paneth cells or tuft cells, respec-
tively (Biton et al., 2018). By contrast, the anti-inflammatory cytokine 
interleukin-10 (IL-10) promotes stem cell self-renewal (Biton et al., 
2018). Therefore, the immune system directs epithelial adaptation by 
modulating stem cell renewal or differentiation, in order to specifically 
target the respective infectious agent. Stem cells have also been shown 
to act as primary epithelial sensors and pro-inflammatory mediators of 
bacterial infections. In the context of H. pylori infection, both organoids 
and a polarized air-liquid interface model of the gastric epithelium have 
shown that Wnt-responsive stem cells induce high pro-inflammatory 
responses to infection, while differentiated surface epithelial cells do 
not (Bartfeld et al., 2014; Boccellato et al., 2018). Accordingly, the 
severity of gastritis has been shown to correlate with the ability of H. 
pylori to colonize deep in the gland (Sigal et al., 2015). Similarly, a study 
using intestinal organoids, which was recently published as a preprint, 
confirmed that also in the intestinal crypt base, stem cells appear to be 
the main responders to bacteria, through upregulation of the nuclear 
factor-κB (NF-κB) pathway (Meddens CA et al., preprint SSRN#3,485, 
163). Thus, in addition to orchestrating epithelial homeostasis, once 
they come into contact with bacteria, stem cells appear to trigger an 
inflammatory reaction. 
While stem cells are critical for homeostasis and important for 
defence, infection and the subsequent acute inflammation can lead to 
their depletion or reprogramming. Intestinal epithelial cells exhibit a 
high degree of cellular plasticity and de-differentiation of various 
different cell types can provide an alternative source of stem cells upon 
tissue damage. Inflammatory pathways can enhance Wnt-signalling, 
leading to the de-differentiation of epithelial non-stem cells (Schwi-
talla et al., 2013). Inflammation caused by administration of dextran 
sulfate sodium (DSS) has been shown to cause loss of stem cells in the 
small intestine of mice, which can be replaced by Paneth cells that have 
undergone de-differentiation (Schmitt et al., 2018). Bmi1-expressing 
cells in the small intestine that reside above the crypt base have also 
been shown to act as a reserve stem cell pool in case of injury (Tian et al., 
2011; Yan et al., 2012). Additionally, secretory progenitor cells 
expressing the Notch ligand Dll1 revert to stem cells upon crypt damage 
in the small intestine (van Es et al., 2012). Alkaline phosphate intestinal 
(Alpi)-expressing short-lived enterocyte precursors can de-differentiate 
to replace lost Lgr5+ stem cells and Paneth-like cells in the small in-
testine (Tetteh et al., 2016). Similarly, Keratin-19+/Lgr5− cells above 
the crypt base in the small intestine and colon can replace Lgr5+ stem 
cells (Asfaha et al., 2015). In the colon, two stem cell populations have 
been identified, Lgr5+/Axin2+ cells at the base of the crypt, and 
secretory Lgr5− /Axin2+ cells just above the base. Administration of 
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DSS to mice leads to loss of Lgr5+ and Axin2+ cells, and differentiated 
Axin2− /Keratin-20+ enterocytes are then recruited to repopulate the 
injured crypt. This process is mediated by increased levels of stromal 
R-spondin 3 in response to the epithelial damage (Harnack et al., 2019). 
The epithelium is also known to repopulate itself through crypt fission if 
crypts die or are lost due to damage (de Sousa and de Sauvage, 2019). 
This remarkable plasticity of the intestinal epithelium ensures regener-
ation and restoration of tissue integrity in response to infection and 
injury. It will be important to explore to what extent members of the 
microbiota or pathogens are involved in these complex processes, and 
how transient loss of stem cells affects the ability of the epithelium to 
maintain a barrier and fight infections. 
4. Paneth cells and antimicrobial peptides 
In the small intestine, Paneth cells, which are located in close 
proximity to crypt base stem cells, are a major source of antimicrobial 
peptides (AMPs), while in the colon, enterocytes secrete a variety of 
AMPs. These peptides are a crucial component of the epithelial barrier 
and have antimicrobial activity against a number of potential pathogens. 
Paneth cells secrete α-defensins, lysozyme, phospholipase A2, and RN-
ases. Colonocytes secrete β-defensins and cathelicidins. C-type lectins 
are secreted by enterocytes in both the small and large intestine. 
Galectins, lipocalin, and peptidoglycan recognition proteins are further 
AMPs that are expressed throughout the intestinal tract (Gallo and 
Hooper, 2012). AMPs have different modes of action and can act on a 
broad range of microbes. The expression of some AMPs requires 
microbiota-derived signals: Ang4, an RNase expressed by Paneth cells, 
could be induced by infecting mice with the gut commensal Bacteroides 
thetaiotaomicron, showing that commensals shape innate immunity 
(Hooper et al., 2003). Similarly, RegIIIγ, a C-type lectin, is secreted by 
Paneth cells upon microbial colonization of germ-free mice (Cash et al., 
2006), and is essential for maintaining an area directly above the 
epithelium ~50 μm deep, which is not colonized by the microbiota 
(Vaishnava et al., 2011). Furthermore, intestinal goblet cells have been 
shown to produce resistin-like molecule β (RELMβ) (Artis et al., 2004), 
which is induced by the microbiota and kills Gram-negative bacteria, 
and is essential for maintaining the spatial segregation of the intestinal 
microbiota (Propheter et al., 2017). Mice lacking an enzyme required for 
the processing of mouse α-defensins have microbial dysbiosis and 
enhanced inflammation (Salzman et al., 2010). Defensins were shown to 
undergo post-translational activation, such as reduction of disulphide 
bonds, which makes them more potent in the reducing environment of 
the intestinal lumen (Schroeder et al., 2011). Monocytes can induce the 
expression of defensins in Paneth cells by secreting Wnt ligands. How-
ever, expression of Wnt ligands in monocytes is compromised in patients 
with Crohn’s disease (CD), resulting in a reduced ability to induce 
defensins (Courth et al., 2015). CD patients also show reduced expres-
sion of the Wnt signalling transcription factor Tcf-4, resulting in a 
decrease of Paneth cell α-defensins, further weakening the mucosal 
defence (Wehkamp et al., 2007). While Paneth cells are only present in 
the small intestine, unique populations of gland base secretory cells with 
antimicrobial properties can be found throughout the gastrointestinal 
tract, such as gastric gland base mucous cells (Sigal et al., 2019) and 
gland base secretory cells in the colon (Rothenberg et al., 2012). These 
cells rely on functional Wnt signalling, suggesting a critical role of this 
signalling pathway for mucosal antimicrobial defence. The release of 
defensins from Paneth cells has also been found to be stimulated in 
response to the pro-inflammatory cytokine interferon gamma (IFN-γ) 
(Farin et al., 2014). CpG-oligodeoxynucleotide (ODN), an agonist of 
TLR9, given orally to mice induced Paneth cell degranulation, but not in 
Tlr9− /− mice (Rumio et al., 2012). Other factors, such as 
acetylcholine-expressing T cells (Dhawan et al., 2016) and interleukins 
(IL-4 and IL-13) (Stockinger et al., 2014) have also been shown to induce 
Paneth cell degranulation and AMP secretion. Taken together, the 
bactericidal activity of AMPs regulates commensals and provides the 
epithelium with vital protection against pathogens. 
5. Goblet cells 
Goblet cells secrete mucus, a viscous fluid enriched in mucin glyco-
proteins, which form large net-like polymers, lubricate the epithelial 
surface, and generate a protective physical barrier against luminal mi-
crobes. The continuous production of mucus by goblet cells also creates 
an upward flow in the crypts, preventing bacterial infiltration (Pela-
seyed et al., 2014). The mucus layer in the intestine is composed of 
gel-forming Mucin-2 (MUC2). In the colon, the mucus is composed of 
two layers, an inner firm mucus layer and an outer loose mucus layer. In 
the small intestine, this separation is less stringent. In humans, the inner 
layer is a dense, stratified layer that does not allow microorganisms to 
penetrate easily, thus keeping the epithelium free from intestinal mi-
crobes (Johansson et al., 2008). The outer mucus layer is less dense and 
is inhabited by a large number of intestinal microbes that utilize poly-
saccharides of MUC2 as an energy source (Okumura and Takeda, 2017). 
Commensal microbes have evolved mechanisms to utilize glycans 
(polysaccharides) from the diet and the mucus layer, resulting in the 
production of short-chain fatty acid (SCFA) metabolites, which in turn 
are essential nutrients for the intestinal epithelium (Koropatkin et al., 
2012). Muc2-deficient mice exhibit increased colonic inflammation and 
spontaneously develop colitis (Van der Sluis et al., 2006). As the mi-
crobial density increases from the proximal small intestine to the distal 
colon, so does the percentage of goblet cells, from 4% in the duodenum 
to 16 % in the distal colon (Kim and Ho, 2010). Studies have shown that 
bacterial colonization of the intestinal tract plays an essential role in 
Fig. 1. Anatomy and cell types of the intestinal epithelium. 
A) The mucosa of the small intestine is organized into invaginations called crypts and protrusions called villi. LGR5 (leucine-rich repeat-containing G-protein coupled 
receptor 5) expressing stem cells and Paneth cells are present at the crypt base. Paneth cells secrete Wnt and are the main source of antimicrobial peptides (AMPs), 
which protect the stem cell niche and the mucosa from luminal microbes. Stem cells give rise to proliferating transit-amplifying (TA) cells. TA cells differentiate into 
the various functional cell types and replace the cells that are extruded at the tip of the villi. The turnover period of the small intestinal epithelium is 3–5 days. Goblet 
cells secrete mucus, the enteroendocrine cells secrete hormones, and tuft cells protect the host from parasitic infections. Enterocytes are the most abundant epithelial 
cell lineage and take up nutrients from digestive residues. Tight junction proteins seal the monolayer and prevent microbial invasion through the paracellular 
pathway. Microfold cells (M cells) cover underlying Peyer’s patches that contain high numbers of dendritic cells, macrophages, and lymphocytes (T cells and B cells). 
M cells transport antigens and microorganisms to the immune cells beneath. Immunoglobulin A (IgA), which is secreted by subepithelial plasma B cells, is trans-
cytosed by the epithelium into the lumen. 
B) The large intestinal mucosa shares several characteristics with that of the small intestine, with some key differences. The epithelium of the large intestine consists 
of crypts and a flat luminal surface, lacking the villi found in the small intestine. LGR5+ stem cells are located at the base of the crypt and gland base secretory cells 
and transit-amplifying (TA) cells are present just above them. Gland base secretory cells represent a subpopulation of goblet cells that express antimicrobial markers, 
such as REG4. Paneth cells are absent. TA cells give rise to the differentiated cell lineages and epithelial turnover occurs every 5–7 days. Goblet cells secrete mucus, 
which consists of an inner firm mucus layer and an outer loose mucus layer. As the large intestine is more densely populated by microbes than the small intestine, the 
inner mucus prevents them from penetrating the crypts. Sentinel goblet cells guard the crypt entrance and extrude mucus in response to invading bacteria. A large 
number of intestinal microbes reside in the outer mucus layer and break down mucins and dietary fibre to produce short-chain fatty acids (SCFAs), an essential source 
of nutrition for the epithelium. Enterocytes take up nutrients and secrete AMPs. 
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mucus production. Germ-free mice have fewer goblet cells, lower 
expression levels of Muc2, and a very thin mucus layer (Allaire et al., 
2018). These mice have a lower abundance of glycosyltransferase, an 
enzyme involved in Muc2 glycosylation, resulting in shorter Muc2 gly-
cans and therefore thinner mucus layer (Arike et al., 2017). Once 
exposed to a conventional environment, the colonization by commensal 
bacteria results in increased numbers of goblet cells, higher expression 
of the goblet-specific protein RELMβ and thickening of the mucus layer 
(He et al., 2003). Goblet cell mucus secretion is regulated by the 
NOD-like receptor family pyrin domain–containing 6 (Nlrp6) inflam-
masome, and mice deficient for Nlrp6 are unable to clear enteric path-
ogens and are highly susceptible to persistent colonic infection 
(Wlodarska et al., 2014). Sentinel goblet cells guard the colonic crypt 
entrance by activating the Nlrp6 inflammasome in response to bacterial 
intruders, triggering mucin exocytosis and inducing mucus secretion 
from adjacent goblet cells in the upper crypt, leading to expulsion of the 
bacteria (Birchenough et al., 2016). 
Apart from mucus production for barrier maintenance, goblet cells 
also produce several important proteins such as intestinal trefoil factor 3 
(TFF3) and resistin-like molecule-β (RELMβ). TFF3 stabilizes and aids 
the formation of the mucus gel layer by cross-linking mucin glycopro-
teins (Jarva et al., 2020; Kindon et al., 1995). Trefoil peptides play an 
important role in mucosal healing and intestinal trefoil factor deficient 
mice exhibit increased sensitivity to intestinal damage and reduced 
epithelial healing after oral DSS challenge (Mashimo et al., 1996). 
RELMβ is a cysteine-rich cytokine and studies in RELMβ-deficient mice 
have demonstrated that this protein is involved in the maintenance of 
colonic barrier integrity and regulates susceptibility to inflammation 
(Hogan et al., 2006). RELMβ protects against enteric pathogens by 
recruiting CD4+ T cells, which produce interleukin-22 (IL-22), a cyto-
kine that directly increases epithelial cell proliferation (Bergstrom et al., 
2015). In response to infection in mice, IL-22 also induces C-type lectin 
antimicrobial proteins, RegIIIβ and RegIIIγ in colonic epithelial cells 
(Zheng et al., 2008). Further, goblet cells form goblet cell-associated 
antigen passages (GAPs) that deliver luminal substances to underlying 
antigen-presenting cells (APCs) in the lamina propria, inducing adaptive 
immune responses (Knoop et al., 2015; McDole et al., 2012). Therefore, 
goblet cell functions play a fundamental role in innate and adaptive 
immunity. 
6. Enterocyte-microbiota homeostasis 
During homeostasis, the colon microbiota is dominated by obligate 
anaerobic bacteria that convert fibre into fermentation products, such as 
butyrate, propionate, and acetate. These SCFAs are a critical energy 
source for the colon epithelium. Oxidation of SCFAs by enterocytes 
maintains epithelial hypoxia, which in turn ensures that the microbial 
community is dominated by the beneficial obligate anaerobes (Litvak 
et al., 2018). During homeostatic conditions, these metabolic processes 
support microbial diversity in the colon, which appears to be important 
for various physiological processes. Inflammation can disrupt this ho-
meostasis, due to oxygenation of the colon by generation of reactive 
nitrogen species (RNS) and reactive oxygen species (ROS). 
Host-mediated inflammation causes overgrowth of resident or intro-
duced facultative anaerobic bacteria in mice, particularly the Entero-
bacteriaceae family (Lupp et al., 2007). The nitrate generated as a 
by-product of the inflammatory response is host-derived, as mice defi-
cient in inducible nitric oxide synthase do not support the growth of 
commensal Escherichia coli by nitrate respiration in the colon (Winter 
et al., 2013). Nutritional imbalance or enhanced inflammatory signals 
can shift the metabolic activity of the colonic epithelium from lipid 
oxidation toward anaerobic glycolysis, which increases the abundance 
of facultative anaerobic bacteria, a hallmark of dysbiosis (Litvak et al., 
2018). One such facultative anaerobe, Citrobacter rodentium, causes 
crypt hyperplasia and expansion of undifferentiated Ki67+ cells in the 
colon. This leads to increased oxygenation of the mucosal surface, which 
reduces the density of obligate anaerobic commensal bacteria, and 
therefore indirectly further supports the expansion of this pathogen 
(Lopez et al., 2016). ROS generated during inflammation reacts with the 
luminal sulphur compound thiosulphate to form tetrathionate. Salmo-
nella Typhimurium has the ability to use tetrathionate as an electron 
acceptor, giving it a growth advantage over the fermentation-dependent 
commensals (Winter et al., 2010). Similarly, depletion of 
butyrate-producing Clostridia through oral antibiotic treatment alters 
the epithelial metabolism to lactate production, which is utilized by S. 
Typhimurium as a nutrient, allowing the pathogen to outcompete other 
microbes (Gillis et al., 2018; Rivera-Chavez et al., 2016). The host re-
ceptor peroxisome proliferator-activated receptor-γ (PPAR-γ) senses 
butyrate, and a reduction in butyrate-producing bacteria by antibiotic 
treatment leads to decreased PPAR-γ signalling and increased expression 
of nitric oxide synthase. Conversely, microbiota-induced PPAR-γ sig-
nalling limits luminal oxygen bioavailability and prevents dysbiosis and 
expansion of Escherichia and Salmonella strains (Byndloss et al., 2017). 
SCFAs also play a role in adaptive immunity, as they regulate the proper 
development and function of regulatory T cells in the colon (Arpaia 
et al., 2013; Furusawa et al., 2013; Smith et al., 2013). Enterocyte 
metabolic processes that maintain epithelial hypoxia are therefore 
essential to restrict the growth of facultative anaerobes and pathogens. 
7. Enteroendocrine cells 
Intestinal enteroendocrine cells taken together constitute the largest 
endocrine system in the human body (Beumer et al., 2018). In addition 
to secretion of multiple regulatory peptide hormones that serve para-
crine and endocrine functions that mediate digestion, these cells can also 
sense gut microbiota and their metabolites (Yu et al., 2020). Enter-
oendocrine cells are also known to secrete cytokines in response to mi-
crobial metabolites, thus directly influencing the intestinal mucosal 
immune system (Worthington et al., 2018). Spore-forming bacteria from 
mouse and human colon microbiota produce SCFAs that promote host 
serotonin biosynthesis by enteroendocrine cells (Reigstad et al., 2015), 
which has an impact on gastrointestinal motility and platelet function 
(Yano et al., 2015). Reduced expression of serotonin decreases secretion 
of antimicrobial peptides and increases susceptibility to colitis and 
sepsis after infection with S. Typhimurium (Essien et al., 2013). Enter-
oendocrine cells have cytokine receptors, and cytokines from activated 
CD4+ T cells interact with enteroendocrine cells to enhance the pro-
duction of serotonin in the colon after infection of mice with the nem-
atode Trichuris muris (Wang et al., 2007). Glucagon-like peptide-2 
(GLP-2) is a hormone secreted by enteroendocrine cells, and in GLP-2 
receptor deficient (Glp2r− /− ) mice Paneth cell antimicrobial activity 
was found to be reduced and bacterial colonization of the small intestine 
significantly increased (Lee et al., 2012). GLP-2 was also shown to 
enhance the small intestinal epithelial barrier function in mice 
(Benjamin et al., 2000). Enteroendocrine cells can sense lipopolysac-
charides (LPS), and show enhanced secretion of glucagon-like peptide-1 
(GLP-1), a hormone that attenuates inflammation (Lebrun et al., 2017). 
Ablated Paneth cells in the small intestine are replaced by enter-
oendocrine and tuft cells, and these cells serve as an alternative source of 
Notch signals, which are essential for Lgr5+ stem cell maintenance (van 
Es et al., 2019). The functional diversity of enteroendocrine cells and 
their role in epithelial homeostasis and immunity is currently under 
active investigation, driven by the broad availability of single-cell 
characterization approaches. 
8. Mechanisms to maintain a physical epithelial barrier 
As summarized above, a multitude of cellular responses prevent 
direct interaction between the epithelium and microbes. However, 
bacteria do have the ability to bypass these defence mechanisms to reach 
the epithelium. Therefore, the cells are additionally equipped to prevent 
penetration of bacteria through the epithelium, by forming a tightly 
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closed monolayer with intercellular junctions. Tight junction proteins 
link epithelial cells and physically hamper microbial invasion through 
the paracellular pathway. Tight junctional complexes are located at the 
apical pole of the epithelial cells and include occludins, zonula occlu-
dens, claudins, and junctional adhesion molecules to create a seal and 
regulate epithelial permeability (Ashida et al., 2011). Tight junctions are 
highly dynamic structures and several physiological and pathophysio-
logical conditions regulate their permeability. Pro-inflammatory cyto-
kines, such as interferon-gamma (IFN-γ), tumour necrosis factor-alpha 
(TNF-α), and interleukins, can disrupt tight junctions and impair gut 
barrier integrity (Heller et al., 2008; Rawat et al., 2020; Wang et al., 
2006). In addition, some pathogens have developed mechanisms to 
breach the tight-junction integrity. For example, Clostridium perfringens 
produces an enterotoxin that can disintegrate claudins by binding to 
them, thereby increasing paracellular permeability (Saitoh et al., 2015). 
Vibrio cholerae produces zonula occludens toxin (ZOT), which interacts 
with occludins and zonula occludens 1 (ZO1) protein and increases 
mucosal permeability (Fasano et al., 1991). Enterotoxigenic Bacteroides 
fragilis produces B. fragilis toxin (BFT), which alters tight-junction 
integrity of intestinal epithelial cells by cleaving E-cadherin, the extra-
cellular domain of the zonula adherens protein (Wu et al., 1998). Sal-
monella secretes specific effector proteins and pathogenic E. coli strains 
can synthesize a protein kinase, both of which disrupt host intestinal 
epithelial tight junctions (Boyle et al., 2006; Tomson et al., 2004). 
Junctional adhesion molecule-A (JAM-A) deficient mice have a 
compromised epithelial barrier and increased susceptibility to DSS 
induced colitis (Laukoetter et al., 2007). However, these mice do not 
develop spontaneous colitis, due to adaptive immune-mediated protec-
tion. Specifically, TGF-β-producing CD4+ T cells promote IgA secretion, 
protecting against colitis (Khounlotham et al., 2012). These data 
demonstrate the significant role of tight junctions for maintaining an 
intact epithelium, and pathogens that can circumvent this barrier can 
gain entry into the subepithelial host tissue and potentially cause sys-
temic infection. 
9. Epithelium as an active interface between the environment 
and the immune system 
9.1. Epithelium as immune sensor of microbes 
In addition to being an efficient barrier effector, the epithelium 
performs the critical function of sensing pathogens and mediating im-
mune responses. It is equipped with a variety of sensors to induce an 
immune response and act as an active interface that integrates envi-
ronmental signals to either drive or suppress an immune reaction. 
Detection of bacteria is mediated via pattern recognition receptors 
(PRR). Epithelial PRRs sense and recognize both commensal and path-
ogenic microorganisms by their microbial-associated molecular patterns 
(MAMPs). There are two main categories of PRRs that induce tran-
scriptional responses, Toll-like receptors (TLRs) and NOD-like receptors 
(NLRs). 
TLRs activate four adaptor proteins: Myeloid differentiation primary 
response 88 (MYD88), Toll-receptor-associated activator of interferon 
(TRIF), MyD88-adaptor-like/TIR-associated protein (MAL/TIRAP), and 
Toll-receptor-associated molecule (TRAM), which leads to the activation 
of the transcription factor NF-κB (Beutler, 2004). TLR4 recognizes LPS, 
which is mainly present on the outer membrane of Gram-negative bac-
teria. TLR4 signalling through MyD88 is important in intestinal re-
sponses to injury and limiting bacterial translocation. Tlr4-deficient 
mice have defective innate immune responses and are more susceptible 
to DSS-induced colitis (Fukata et al., 2005). Paneth cells directly sense 
both commensal and pathogenic bacteria through cell-autonomous 
MyD88-dependent TLR activation, triggering expression of multiple 
antimicrobial factors (Vaishnava et al., 2008). Deletion of Myd88 in 
intestinal epithelial cells causes a compromised immunological 
response, with more mucus-associated bacteria and increased bacterial 
translocation. These mice also show downregulated expression of Muc2, 
IgA transporter, and antibacterial peptides (Frantz et al., 2012). TLR5 
detects bacterial flagellin and Tlr5-deficient mice harbour more pro-
teobacteria and develop colitis (Carvalho et al., 2012). Due to changes in 
the composition of their gut microbiota, Tlr5-deficient mice also display 
classic features of metabolic syndrome, including hyperlipidemia, hy-
pertension, insulin resistance, and increased adiposity (Vijay-Kumar 
et al., 2010). TLR3 is a virus-specific PRR that has an asymmetric dis-
tribution towards the basolateral side. Using primary human intestinal 
cells, it was shown that this is a mechanism that promotes tolerance of 
apical commensals present in the lumen, while remaining fully 
responsive to invading pathogens (Stanifer et al., 2020). 
NOD1 detects the DAP-type tri-peptide motif of peptidoglycan pre-
sent on bacteria. Activation of small Rho GTPases in host cells by 
effector proteins of Salmonella triggers NOD1 and activation of the NF- 
κB pathway (Keestra et al., 2013). NOD2 recognizes muramyl dipeptide 
(MDP), another peptidoglycan motif present on bacteria. NOD2 both 
regulates commensal bacteria and depends on the presence of 
commensal bacteria for its expression. Nod2-deficient mice have an 
increased load of commensal bacteria and a diminished ability to pre-
vent colonization with pathogenic bacteria (Petnicki-Ocwieja et al., 
2009). Paneth cells of Nod2-deficient mice have lower expression of 
anti-microbial peptides and show increased susceptibility to the 
gastrointestinal pathogen Listeria monocytogenes (Kobayashi et al., 
2005). Moreover, Nod2 is known to be one of the susceptibility genes for 
inflammatory bowel disease (IBD), indicating a crucial role of PRRs in 
maintaining epithelial homeostasis, where their dysfunction can lead to 
a disbalance between microbes and the mucosa, resulting in chronic 
inflammation. Overall, these results indicate that PRRs are important for 
stimulating antimicrobial defences, shaping the microbiota, and pro-
tecting the epithelium from pathogenic invasion. 
9.2. Tuft cells 
Tuft cells play a vital role in the defence against helminths, as they 
promote type 2 immunity in response to intestinal parasitic infections 
(Howitt et al., 2016). Tuft cells secrete interleukin-25 (IL-25), thereby 
activating type 2 innate lymphoid cells (ILC2s). In the small intestine, 
interleukin 4 (IL-4) and interleukin 13 (IL-13) signals produced by ILC2s 
in response to parasitic infections cause stem cell differentiation towards 
goblet and tuft cells (Gerbe et al., 2016; von Moltke et al., 2016). Tuft 
cell hyperplasia is seen in the small intestine of mice infected with the 
tapeworm species Hymenolepis diminuta (Rajeev et al., 2020). Secreted 
IL-25 provides immunity against reinfection and contributes to infection 
resistance in the host (Schneider et al., 2018). Tuft cells also monitor 
microbial metabolites, such as succinate, to initiate type 2 immunity. 
Succinate receptor 1 (Sucnr1) is specifically expressed in small intestinal 
tuft cells and senses succinate secreted by the microbiota and helminths 
(Lei et al., 2018; Nadjsombati et al., 2018). In addition, 
doublecortin-like kinase 1 (Dclk1) expressed by tuft cells has been 
shown to play a role in epithelial restorative responses in mice after DSS 
treatment (Qu et al., 2015) and following radiation-induced injury (May 
et al., 2014). Thus, apart from protecting the host from helminth in-
fections, tuft cells also contribute to recovery after epithelial damage. 
9.3. Microfold cells 
Microfold cells (M cells) are specialized absorptive epithelial cells 
present in the small intestinal mucosa, which play an important role in 
mucosal immune surveillance. They cover the underlying Peyer’s 
patches - mucosa-associated lymphoid follicles that contain high 
numbers of lymphocytes, macrophages, and dendritic cells. M cells 
sample the intestinal lumen and transport antigens, immunoglobulin A 
(IgA)-containing immune complexes or whole microorganisms to the 
immune cells beneath, thereby initiating an immune response or toler-
ance. Glycoprotein 2 (GP2) expressed on the apical plasma membrane of 
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M cells binds to FimH, a type 1 pili component of commensal and 
pathogenic enterobacteria, to trigger an antigen-specific immune 
response (Hase et al., 2009). Uromodulin, a GP2 homolog present on M 
cells, can also bind to FimH-positive bacteria (Sato et al., 2013). M cell 
differentiation is dependent on receptor activator of nuclear factor-κB 
ligand (RANKL). They express osteoprotegerin (OPG), a soluble inhibi-
tor of RANKL, which suppresses the differentiation of adjacent 
follicle-associated epithelial cells into M cells, thereby regulating M-cell 
density (Kimura et al., 2020). Treatment of intestinal organoids with 
RANKL induces expression of M cell-specific markers and increases M 
cell numbers (de Lau et al., 2012). Targeted delivery of vaccine antigens 
to M cells could be a potential means of inducing antigen-specific 
mucosal immune responses (Mabbott et al., 2013). 
9.4. Immunoglobulin A transcytosis 
In addition to maintaining the barrier in an autonomous manner, the 
epithelium actively communicates with immune cells. One example of 
this is their active role in immunoglobulin A (IgA) delivery to the lumen. 
IgA constitutes the main antibody isotype secreted in the gut and plays 
an essential role in maintaining homeostasis between host tissues and 
intestinal microbial communities (Macpherson et al., 2000). IgA anti-
bodies are secreted from subepithelial plasma cells and transcytosed 
across the epithelium into the lumen. Luminal IgA provides an antigenic 
barrier by binding to bacteria and preventing colonization by pathogens 
and overgrowth of pathobionts. Clumping of bacteria by IgA-mediated 
cross-linking accelerates pathogen clearance from the gut lumen 
(Moor et al., 2017). The active transport of IgA is mediated by the 
epithelial polymeric Ig receptor (pIgR). pIgR knockout mice that are 
unable to trancytose IgA into the intestinal lumen have been shown to 
have increased mucosal leakiness and increased presence of bacteria in 
the mesenteric lymph nodes (Johansen et al., 1999). In primary colonic 
epithelial cell monolayer cultures, pIgR expression and IgA transcytosis 
can be stimulated by LPS, TNF-α, IL-1β, IL-17, and heat-killed E. coli 
(Moon et al., 2014). Dendritic cells can retain live commensal bacteria 
for several days and interact with naive B cells in the mesenteric lymph 
nodes to induce production of IgA, thus preventing mucosal penetration 
by commensals. These commensal-carrying dendritic cells are restricted 
to the mucosal immune compartment, therefore ensuring a local im-
mune response (Macpherson and Uhr, 2004). In germ-free mice pro-
duction of intestinal plasma cells and secretion of IgA is induced in 
response to exposure to commensals (Hapfelmeier et al., 2010). B-cell 
development has been shown to occur in the intestinal mucosa, where it 
is regulated by extracellular signals from commensal microbes, which 
were again absent in germ-free mice (Wesemann et al., 2013). Mice that 
have impaired capacity of B cells to undergo somatic hypermutation, 
thereby limiting the diversity of their secretory IgA repertoire, were 
shown to have reduced mucosal defence against toxins and pathogens 
(Suzuki et al., 2004; Wei et al., 2011). In summary, homeostatic barrier 
function requires a functional immune system and close co-operation 
with the epithelium that mediates the immune response through pro-
cesses such as IgA transcytosis. 
10. Organoids as an infection model 
Organoids are three-dimensional primary epithelial cell cultures that 
closely mimic the structure and physiology of the source tissue (Sato 
et al., 2009). While initially used to study epithelial stem cell biology 
and development, they have recently proven to be a valuable tool for 
investigating host-microbial interactions in the gastrointestinal tract, as 
they enable infection of untransformed, healthy epithelial cells in vitro. 
Several studies have used gastric organoids to study epithelial responses 
to the gastric pathogen H. pylori. Infection of human gastric organoids 
with H. pylori was shown to activate the NF-κB inflammatory pathway 
(Bartfeld et al., 2014). Epithelial responses to H. pylori were also studied 
by infecting primary cells that were first grown as organoids and then 
transferred to 2-dimensional as well as air-liquid interface cultures 
(Boccellato et al., 2018; Morey et al., 2018; Schlaermann et al., 2016). In 
addition, chemoattraction of H. pylori to urea from gastric epithelial cells 
was demonstrated using organoid cultures (Huang et al., 2015). The 
ability to infect untransformed primary epithelial cells is particularly 
useful for studying H. pylori driven carcinogenesis. For example, a host 
tumour suppressor, apoptosis-stimulating protein of p53 2 (ASPP2), was 
found to play a vital role in the disruption of cell polarity by CagA during 
H. pylori infection of gastric organoids (Buti et al., 2020). 
Intestinal organoids have also been used for infection studies: S. 
Typhimurium was shown to invade epithelial cells of intestinal orga-
noids, disrupt tight junctions, reduce expression of stem cell markers, 
and trigger inflammation (Forbester et al., 2015; Zhang et al., 2014). In 
an alternative approach, the epithelial polarity of organoids was 
reversed by manipulating extracellular matrix (ECM) proteins. Infection 
of these apical-side-out enteroids with S. Typhimurium showed that this 
pathogen invades the apical surfaces by inducing cytoskeletal rear-
rangements, whereas Listeria monocytogenes, which binds to basolateral 
receptors, invades apical surfaces at the sites of extruding cells (Co et al., 
2019). Infection of intestinal organoids with Clostridioides difficile or the 
purified toxin from the bacteria was shown to disrupt epithelial barrier 
function (Leslie et al., 2015). In addition, reduction in colonic organoid 
formation was observed from crypts isolated from C. difficile infected 
mice (Mileto et al., 2020). Intestinal organoids have also been used to 
study the interplay between microbial and immune factors. For 
example, interferon-gamma (IFN-γ) was shown to trigger degranulation 
and luminal extrusion of Paneth cells in intestinal organoids following 
addition of microbial antigens to the culture medium or infection with 
E. coli (Farin et al., 2014). 
Additionally, intestinal organoids have been used to study the role of 
genotoxic bacteria in inducing mutations and transforming epithelial 
cells: S. Typhimurium has been shown to activate the MAPK and AKT 
pathways and induce cellular transformation in gallbladder organoids 
with pre-existing mutations affecting p53 and c-Myc (Scanu et al., 
2015). S. Typhimurium can also induce DNA double-strand breaks in 
gallbladder organoids, and primary cells intoxicated with the typhoid 
toxin were shown to proliferate despite the presence of DNA damage 
(Sepe et al., 2020). Repeated luminal injection of genotoxic 
colibactin-producing pks+ E. coli in human intestinal organoids was 
shown to give rise to a specific mutational signature that was also 
detected in a subset of human colorectal cancer (Pleguezuelos-Manzano 
et al., 2020). Similarly, infection of Caco-2 cells with pks+ E. coli showed 
an enrichment of DNA double-strand breaks at AT-rich hexameric 
sequence motif, and this motif was also detected to be enriched in 
colorectal cancer (Dziubanska-Kusibab et al., 2020). We utilized colon 
organoids to study the transformation potential of pks+ E. coli upon 
short-term infection. After infection, organoids were observed to in-
crease their proliferative activity and grow independent of exogenous 
Wnt ligands (Iftekhar et al., 2021), a characteristic of colorectal cancer 
organoids (Drost et al., 2015; Matano et al., 2015). DNA sequencing 
revealed that these Wnt-independent colon organoids had major chro-
mosomal aberrations, and chromosomal instability (CIN) (Iftekhar et al., 
2021), resembling early events in colorectal cancer (Stoler et al., 1999). 
The Wnt-independent organoids harboured several mutations, including 
miR-34a, which acts downstream of p53 and downregulates the Wnt 
signalling (Kim et al., 2011). We demonstrated a functional interplay 
between the p53 and Wnt pathways, as knockout of Trp53 or miR-34 in 
organoids resulted in Wnt-independent growth (Iftekhar et al., 2021). 
Organoids have also been utilized to study infection by parasitic 
worms. In response to infection by intestinal nematodes, tuft cells pro-
duce IL-25, a cytokine that stimulates secretion of IL-13 by innate 
lymphoid cells, and IL-13 treatment of intestinal organoids markedly 
increases tuft-cell abundance (Luo et al., 2019). Intestinal organoids 
generated from mice infected with H. polygyrus formed spheroids that 
were devoid of crypt budding and exhibited characteristics of prolifer-
ative fetal intestinal epithelium (Nusse et al., 2018). Extracellular 
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vesicles secreted by Trichuris muris and Nippostrongylus brasiliensis were 
demonstrated to be internalized by murine intestinal organoid cells 
(Eichenberger et al., 2018a, b). The protozoan parasite Cryptosporidium, 
which could so far not be cultured in vitro, was shown to grow and 
complete its life cycle in differentiated human intestinal organoids (Heo 
et al., 2018). Similarly, intestinal organoids and monolayers derived 
from them also support the replication of enteric viruses that have been 
difficult to culture in cell lines, such as rotavirus and norovirus (Ettayebi 
et al., 2016; Finkbeiner et al., 2012). More recently, it was observed that 
some COVID-19 patients experience gastrointestinal symptoms, and 
human intestinal organoids were successfully used to show that 
SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is highly 
expressed on differentiated enterocytes. In these cells, SARS-CoV-2 can 
actively replicate and give rise to large numbers of new infective virus 
particles (Lamers et al., 2020). Similar results were also shown for in-
testinal organoids derived from horseshoe bats (Zhou et al., 2020). We 
demonstrated using human colon organoids that IFN-γ promotes dif-
ferentiation of enterocytes, increasing SARS-CoV-2 susceptibility (Heu-
berger et al., 2021). Organoids are therefore a promising new in vitro 
tool for disease modelling and for conducting mechanistic studies to 
better understand host-pathogen interactions and the response of pri-
mary epithelial cells to infection. 
11. Outlook 
As elucidated in this review, the gastrointestinal mucosa is much 
more than a physical border between the host and the environment. Its 
dynamic turnover kinetics, controlled by stem cells, enable a rapid and 
targeted adaptation of the epithelium to environmental perturbations. 
The epithelium represents an active hub that integrates and transmits a 
variety of signals, both from the microbiota as well as from the endog-
enous niche, in order to mediate immune responses, which in turn affect 
mucosal defence, epithelial turnover, and cell composition. It is 
composed of a variety of cell types, each of which contributes to the 
barrier function and is equipped with a specific set of sensors and ef-
fectors to fight infections and regulate the microbiota. This concept 
could be significantly expanded by integrating the role of the healthy 
microbiota in shaping mucosal homeostasis and providing critical sig-
nals that control epithelial behaviour and its adaptation capacity. In 
contrast, altered microbiota composition, so-called dysbiosis, can be 
both cause and result of altered epithelial homeostasis, initiating pro- 
inflammatory trajectories and enhancing the risk of chronic gut disor-
ders such as inflammatory bowel diseases or gastrointestinal cancers. 
While it is well-established that genetic predispositions, such as lack of 
defensins or other antimicrobial compounds, are linked to inflammatory 
and malignant disorders, it will be important to investigate whether and 
to what extent an altered epithelial adaptation capacity contributes to 
pathogenesis of gastrointestinal disorders. In this context, new tech-
nologies such as single-cell sequencing and spatial transcriptomics will 
be useful to resolve tissue responses at single-cell resolution. This may 
provide new clinical intervention strategies for re-setting the homeo-
stasis between the microbiota and the mucosa, which could potentially 
be achieved by targeting both the microbial composition, as well as 
intrinsic signals that control epithelial differentiation. 
Advances in genome sequencing have also enabled the identification 
of specific colorectal cancer (CRC) signatures, and one specific signature 
found in CRC has been associated with colibactin-producing E. coli, 
which are frequent constituents of the human intestinal microbiota. 
Therefore, in addition to altering mucosal differentiation and prolifer-
ation, both pathogens and microbiota-derived toxins can directly dam-
age epithelial cells and their genomic integrity, which may have a 
profound, long-term impact on epithelial behaviour. Further such 
studies will help to provide a clearer picture of disease-specific micro-
biota composition and to identify other pro-carcinogenic gut bacteria. 
The emergence of new animal models for lineage tracing has addi-
tionally revealed aspects of cell fate and plasticity of the epithelium, 
which will be important to further understand the dynamic cellular re-
sponses to infections. Cells from animals with specific genotypes or from 
human biopsies can be cultivated as organoids and primary epithelial 
monolayer cultures for in vitro investigation of stem cell biology, cancer 
mutations, infection biology, and intrinsic defence mechanisms of in-
testinal epithelial cells. Furthermore, targeted gene editing of organoids 
using CRISPR/Cas9 technology has helped to uncover the specific role of 
genes and cellular pathways. Likewise, in vitro models such as organs-on- 
chips, microfluidic primary human cell culture systems that recapitulate 
the physiological and functional characteristics of cells, are a promising 
tool for disease modelling, drug discovery, and personalized medicine. 
Other cell types, such as stromal cells and immune cells, can be co- 
cultured with primary epithelial cells in these culture systems to anal-
yse the interactions between different cellular compartments. Using 
picoliter droplets, droplet microfluidics has provided a platform for 
isolating microbiota members from stool samples in an anaerobic 
chamber, making it possible to study their metabolic functions and 
susceptibility to antibiotics. Metabolites generated by bacterial species 
in the microbiota can also be analysed by high-throughput metab-
olomics. Overall, aided by these enhanced molecular biology tech-
niques, future findings will further unravel the intricate relationship 
between the epithelium, the immune system, and the gut microbiota. 
These insights will contribute to a better understanding of complex 
epithelial biological processes and to the development of improved 
therapeutic solutions for inflammatory bowel disease, gastrointestinal 
malignancies, and enteric infections. 
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